{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:45:02Z","timestamp":1790775902469,"version":"4.1.0"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:p>Objective. To assess the association between peak total serum bilirubin (PSB) levels during the first 2 weeks of life and neurodevelopmental outcomes of extremely low birth weight (ELBW) infants at 18 to 22 months\u2019 postmenstrual age.<\/jats:p><jats:p>Methods. A retrospective analysis was conducted of a cohort of ELBW infants (401\u20131000 g) who survived to 14 days of age in the 12 participating centers of the National Institute of Child Health and Human Development Neonatal Research Network between January 1, 1994, and December 31, 1997. Demographic and clinical risk factors and PSB levels during the first 14 days were analyzed with reference to death or adverse neurodevelopmental outcomes at 18 to 22 months\u2019 postmenstrual age. The neurodevelopmental variables considered were Psychomotor Developmental Index (PDI) &amp;lt;70, Mental Developmental Index (MDI) &amp;lt;70, moderate or severe cerebral palsy (CP), hearing impairment (needs hearing aids), and a composite category designated as neurodevelopmental impairment (NDI). The NDI is defined as infants with any 1 or more of the following: PDI &amp;lt;70, MDI &amp;lt;70, moderate to severe CP, bilateral blindness, or bilateral hearing impairment requiring amplification.<\/jats:p><jats:p>Results. The subjects of this cohort analysis are infants who were admitted to the Network centers during calendar years 1994\u20131997 and survived beyond 14 days and had PSB recorded during the 14-day period. From this cohort, 3246 infants survived at discharge, 79 died after discharge, and 592 were lost to follow-up. Thus, 2575 of 3167 infants were seen in the follow-up clinics with a compliance rate of 81%. Logistic regression analysis showed that various demographic and clinical variables are associated with poor neurodevelopmental outcomes. After adjustment for these risk factor, significant association were found between PSB (mg\/dL) and death or NDI (odds ratio: 1.068; 95% confidence interval [CI]: 1.03\u20131.11); PDI &amp;lt;70 (R = 1.057; 95% CI: 1.00\u20131.12), and hearing impairment requiring hearing aids (odds ratio: 1138; 95% CI: 1.00\u20131.30). There was no significant association between PSB (mg\/dL) and CP, MDI &amp;lt;70, and NDI.<\/jats:p><jats:p>Conclusions. PSB concentrations during the first 2 weeks of life are directly correlated with death or NDI, hearing impairment, and PDI &amp;lt;70 in ELBW infants. The statistical association based on retrospective analysis of observational data and relatively small effect size should be interpreted with caution. Furthermore, because of the possibility of compounding effects of variables on outcome, the potential benefits of moderate hyperbilirubinemia and the potential adverse effects of phototherapy, a randomized, controlled trial of aggressive and conservative phototherapy is needed to address this controversial issue.<\/jats:p>","DOI":"10.1542\/peds.112.4.773","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"773-779","source":"Crossref","is-referenced-by-count":124,"title":["Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants"],"prefix":"10.1542","volume":"112","author":[{"given":"William","family":"Oh","sequence":"first","affiliation":[{"name":"Women and Infants\u2019 Hospital of Rhode Island\/Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Tyson","sequence":"additional","affiliation":[{"name":"University of Texas-Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avroy A.","family":"Fanaroff","sequence":"additional","affiliation":[{"name":"Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty R.","family":"Vohr","sequence":"additional","affiliation":[{"name":"Women and Infants\u2019 Hospital of Rhode Island\/Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Perritt","sequence":"additional","affiliation":[{"name":"Research Triangle Institute; Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Ehrenkranz","sequence":"additional","affiliation":[{"name":"Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Shankaran","sequence":"additional","affiliation":[{"name":"Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Poole","sequence":"additional","affiliation":[{"name":"Research Triangle Institute; Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Wright","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,10,1]]},"reference":[{"key":"2021121003413420100_R1","unstructured":"Weinberg RP. Cellular basis of bilirubin toxicity. N Y State J Med.1991;91:493\u2013496"},{"key":"2021121003413420100_R2","doi-asserted-by":"crossref","unstructured":"Cashore WJ. The neurotoxicity of bilirubin. Clin Perinatol.1990;17:437\u2013447","DOI":"10.1016\/S0095-5108(18)30577-3"},{"key":"2021121003413420100_R3","doi-asserted-by":"crossref","unstructured":"Wennberg RP, Hance AJ. Experimental encephalopathy: importance of total bilirubin, protein binding and blood brain barrier. Pediatr Res.1986;20:789\u2013792","DOI":"10.1203\/00006450-198608000-00018"},{"key":"2021121003413420100_R4","doi-asserted-by":"crossref","unstructured":"Bratlid D. How bilirubin gets into the brain. Clin Perinatol.1990;17:449\u2013465","DOI":"10.1016\/S0095-5108(18)30578-5"},{"key":"2021121003413420100_R5","doi-asserted-by":"crossref","unstructured":"Stern L, Denton RL. Kernicterus in small premature infants. Pediatrics.1965;35:483\u2013485","DOI":"10.1542\/peds.35.3.483"},{"key":"2021121003413420100_R6","doi-asserted-by":"crossref","unstructured":"Harris RC, Lucey JF, MacLean RJ. Kernicterus in premature infants associated with low concentration of bilirubin in the plasma. Pediatrics.1958;21:875","DOI":"10.1542\/peds.21.6.875"},{"key":"2021121003413420100_R7","doi-asserted-by":"crossref","unstructured":"Gartner LM, Snyder RN, Chabon RS, Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentration. Pediatrics.1970;45:906\u2013917","DOI":"10.1542\/peds.45.6.906"},{"key":"2021121003413420100_R8","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low birth weight infants. Pediatrics.1982;69:481\u2013485","DOI":"10.1542\/peds.69.4.481"},{"key":"2021121003413420100_R9","doi-asserted-by":"crossref","unstructured":"Watchko JF, Claasen D. Kernicterus in premature infants: current prevalence and relationship to NICHD phototherapy exchange criteria. Pediatrics.1994;93:996\u2013999","DOI":"10.1542\/peds.93.6.996"},{"key":"2021121003413420100_R10","unstructured":"Amiel-Tison C. Neuromotor status. In: Taeusch HW, Yogman MW, eds. Follow-up Management of the High-Risk Infant. Boston, MA: Little, Brown Company; 1987:115\u2013126"},{"key":"2021121003413420100_R11","unstructured":"Bayley N. Bayley Scales of Infant Development-II. San Antonio, TX: The Psychological Corporation; 1993"},{"key":"2021121003413420100_R12","doi-asserted-by":"crossref","unstructured":"Hack M, Wilson-Costello D, Friedman H, et al. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g. Arch Pediatr Adolesc Med.2000;154:725\u2013731","DOI":"10.1001\/archpedi.154.7.725"},{"key":"2021121003413420100_R13","doi-asserted-by":"crossref","unstructured":"De Vries LS, Lary S, Dubowitz LMS. Relationship between serum bilirubin levels to ototoxicity and deafness in high-risk low birth weight infants. Pediatrics.1985;76:351\u2013354","DOI":"10.1542\/peds.76.3.351"},{"key":"2021121003413420100_R14","doi-asserted-by":"crossref","unstructured":"Nakamura H, Takada S, Shimabuku R, Matsuo M, Matsuo T, Negishi H. Auditory and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics.1985;75:703\u2013708","DOI":"10.1542\/peds.75.4.703"},{"key":"2021121003413420100_R15","doi-asserted-by":"crossref","unstructured":"Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clin Perinatol.1990;17:293\u2013306","DOI":"10.1016\/S0095-5108(18)30569-4"},{"key":"2021121003413420100_R16","doi-asserted-by":"crossref","unstructured":"Van de Bor M, VanZeben-van der Aa TM, Verloove-Vanhoorick SP, et al. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics.1989;83:915\u2013924","DOI":"10.1542\/peds.83.6.915"},{"key":"2021121003413420100_R17","doi-asserted-by":"crossref","unstructured":"Van de Bor M, Ens-Dokkum M, Schreuder AM, et al. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics.1992;89:359\u2013364","DOI":"10.1542\/peds.89.3.359"},{"key":"2021121003413420100_R18","doi-asserted-by":"crossref","unstructured":"O\u2019Shea TM, Dillard RG, Klinepeter KL, Goldstein DJ. Serum bilirubin levels, intracranial hemorrhage, and the risk of developmental problems in very low birth weight neonates. Pediatrics.1992;90:888\u2013892","DOI":"10.1542\/peds.90.6.888"},{"key":"2021121003413420100_R19","unstructured":"Sampath V, Bowen J, Gibson F. Risk factors for low 5-year IQ in ELBW infants with normal cranial ultrasound [abstract]. Pediatr Res.2002;51:1686"},{"key":"2021121003413420100_R20","unstructured":"Scheidt PC, Bryla DA, Nelson KB, et al. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development Clinical Trial. Pediatrics.1990;85:455\u2013463"},{"key":"2021121003413420100_R21","doi-asserted-by":"crossref","unstructured":"Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the NICHD Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol.1998;179:1632\u20131639","DOI":"10.1016\/S0002-9378(98)70037-7"},{"key":"2021121003413420100_R22","doi-asserted-by":"crossref","unstructured":"Lemons JA, Bauer CR, Oh W, et al: Very-low-birth-weight outcomes of the NICHD Neonatal Research Network, January 1995 through December 1996. Pediatrics.2001;107(1). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/107\/1\/e1","DOI":"10.1542\/peds.107.1.e1"},{"key":"2021121003413420100_R23","doi-asserted-by":"crossref","unstructured":"Blaymore-Bier J, Pezzullo J, Kim E, et al. Outcome of extremely low-birth-weight infants: 1980\u20131990. Acta Pediatr.1994;83:1244\u20131248","DOI":"10.1111\/j.1651-2227.1994.tb13005.x"},{"key":"2021121003413420100_R24","doi-asserted-by":"crossref","unstructured":"Hack M, Horbar JD, Malloy MH, et al. Very low birth weight outcomes of the NICHD neonatal network. Pediatrics.1991;87:587\u2013597","DOI":"10.1542\/peds.87.5.587"},{"key":"2021121003413420100_R25","doi-asserted-by":"crossref","unstructured":"Hack M, Friedman H, Fanaroff AA. Outcomes of extremely low-birth weight infants. Pediatrics.1996;98:931\u2013937","DOI":"10.1542\/peds.98.5.931"},{"key":"2021121003413420100_R26","unstructured":"Victorian Infant Collaborative Study Group: Neurosensory outcome at 5 years in extremely low birth weight. Arch Dis Child Fetal Neonatal Ed.1995;73:43\u201346"},{"key":"2021121003413420100_R27","doi-asserted-by":"crossref","unstructured":"Vohr BR, Wright LL, Dusick AM, et al: Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993\u20131994. Pediatrics.2000;105:1216\u20131225","DOI":"10.1542\/peds.105.6.1216"},{"key":"2021121003413420100_R28","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Horwich A, Karotkin EH, Oh W. Influence of gestational age and clinical status on bilirubin-binding capacity in newborn infants. Am J Dis Child.1977;131:898\u2013901","DOI":"10.1001\/archpedi.1977.02120210076016"},{"key":"2021121003413420100_R29","doi-asserted-by":"crossref","unstructured":"Hansen TW, \u00d8yas\u00c6ter S, Stiris T, Bratlid D. Effects of sulfisoxazole, hypercarbia, and hyperosmolality on entry of bilirubin and albumin into brain regions in young rats. Biol Neonate.1989;56:22\u201330","DOI":"10.1159\/000242983"},{"key":"2021121003413420100_R30","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Oh W, Brodersen R. Bilirubin displacing effect of furosemide and sulfisoxazole: an in vitro and in vivo study in neonatal serum. Dev Pharmacol Ther.1983;6:230\u2013238","DOI":"10.1159\/000457309"},{"key":"2021121003413420100_R31","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Brodersen R, Oh W: Reserve albumin and bilirubin toxicity index in infant serum. Acta Pediatr.1979;72:415\u2013419","DOI":"10.1111\/j.1651-2227.1983.tb09739.x"},{"key":"2021121003413420100_R32","doi-asserted-by":"crossref","unstructured":"Stonestreet BS, Patlak K, Pettigrew C, et al. Ontogeny of blood brain barrier function in ovine fetuses, lambs and adults. Am J Physiol.1996;271:R1594\u2013R1601","DOI":"10.1152\/ajpregu.1996.271.6.R1594"},{"key":"2021121003413420100_R33","doi-asserted-by":"crossref","unstructured":"Lee C, Oh W, Stonestreet BS, Cashore WJ. Permeability of the blood brain barrier for 125 I-albumin bound bilirubin in newborn piglets. Pediatr Res.1989;25:452\u2013456","DOI":"10.1203\/00006450-198905000-00005"},{"key":"2021121003413420100_R34","unstructured":"Dennery PA, McDonagh AF, Stevenson DK. In-vivo role of bilirubin in neonatal antioxidant defenses. Pediatr Res.1992;31:A200"},{"key":"2021121003413420100_R35","doi-asserted-by":"crossref","unstructured":"Sullivan JL, Newton RB. Serum antioxidant activity in neonates. Arch Dis Child.1988;63:748\u2013757","DOI":"10.1136\/adc.63.7_Spec_No.748"},{"key":"2021121003413420100_R36","doi-asserted-by":"crossref","unstructured":"Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett.1994;349:197\u2013200","DOI":"10.1016\/0014-5793(94)00666-0"},{"key":"2021121003413420100_R37","doi-asserted-by":"crossref","unstructured":"Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major cytoprotectant. Proc Natl Acad Sci U S A.2002;99:16063\u201316098","DOI":"10.1073\/pnas.252626999"},{"key":"2021121003413420100_R38","doi-asserted-by":"crossref","unstructured":"Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics.1998;102:1426\u20131431","DOI":"10.1542\/peds.102.6.1426"},{"key":"2021121003413420100_R39","doi-asserted-by":"crossref","unstructured":"McDonagh AF: The role of singlet O2 in bilirubin photooxidation. Biochem Biophys Res Commun.1974;44:1306\u20131309","DOI":"10.1016\/S0006-291X(71)80228-0"},{"key":"2021121003413420100_R40","doi-asserted-by":"crossref","unstructured":"Tozzi E, Ciancarelli MG, Diguida A, et al: In vivo and in vitro effects of erythrocyte phototherapy in newborn. Biol Neonate.1989;56:204\u2013209","DOI":"10.1159\/000243124"},{"key":"2021121003413420100_R41","doi-asserted-by":"crossref","unstructured":"Rosenfeld W, Sadhev S, Brunot V, et al. Phototherapy effects on the incidence of patent ductus arteriosus in premature infants: prevention by chest shielding. Pediatrics.1986;78:10\u201314","DOI":"10.1542\/peds.78.1.10"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/4\/773\/1013687\/pe1003000773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/4\/773\/1013687\/pe1003000773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:36:08Z","timestamp":1682746568000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/4\/773\/63435\/Association-Between-Peak-Serum-Bilirubin-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2003,10,1]]},"published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.4.773","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}